Abstract
The genus Valeriana (Valerianaceae) contains over 250 species distributed around the world and used in traditional medicines of many cultures. The main compounds isolated from Valeriana species are essential oils, valerenic acid and its derivatives and iridoids, accumulated mainly in the roots and rhizomes. This review lists 135 chemical constituents as well as their biosynthesis and bioactivity as reported by the end of 2008 (80 references).
Keywords: Valeriana, biosynthesis, chemical constituents, sesquiterpenoids, iridoids, flavonoids, biological activity
Mini-Reviews in Organic Chemistry
Title: Chemical Constituents of Plants from the Genus Valeriana
Volume: 7 Issue: 2
Author(s): Yufang Wang, Liqing Jin, Shuhong Yu, Qingwen Shi, Yucheng Gu and Hiromasa Kiyota
Affiliation:
Keywords: Valeriana, biosynthesis, chemical constituents, sesquiterpenoids, iridoids, flavonoids, biological activity
Abstract: The genus Valeriana (Valerianaceae) contains over 250 species distributed around the world and used in traditional medicines of many cultures. The main compounds isolated from Valeriana species are essential oils, valerenic acid and its derivatives and iridoids, accumulated mainly in the roots and rhizomes. This review lists 135 chemical constituents as well as their biosynthesis and bioactivity as reported by the end of 2008 (80 references).
Export Options
About this article
Cite this article as:
Wang Yufang, Jin Liqing, Yu Shuhong, Shi Qingwen, Gu Yucheng and Kiyota Hiromasa, Chemical Constituents of Plants from the Genus Valeriana, Mini-Reviews in Organic Chemistry 2010; 7 (2) . https://dx.doi.org/10.2174/157019310791065537
DOI https://dx.doi.org/10.2174/157019310791065537 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mexiletine Metabolites: A Review
Current Medicinal Chemistry Psoriatic Arthritis – Review of the Immunologic, Clinic and Therapeutic Aspects of an Inflammatory Systemic Disease
Current Rheumatology Reviews Lipases Aided Esterification of (2,2-Dimethyl-1,3-dioxolan-4-yl)methanol
Letters in Organic Chemistry Pharmacokinetics of Drugs in Neonates: Pattern Recognition Beyond Compound Specific Observations
Current Pharmaceutical Design Noradrenaline in Parkinsons Disease: From Disease Progression to Current Therapeutics
Current Medicinal Chemistry Cellular, Molecular and Non-Pharmacological Therapeutic Advances for the Treatment of Parkinson's Disease: Separating Hope from Hype
Current Gene Therapy Toll-Like Receptors and their Role in Renal Pathologies
Inflammation & Allergy - Drug Targets (Discontinued) Hydrogen Sulfide and its Modulation in Arterial Hypertension and Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Possible Therapies of Septic Shock: Based on Animal Studies and Clinical Trials
Current Pharmaceutical Design Ranolazine and its Antiarrhythmic Actions
Cardiovascular & Hematological Agents in Medicinal Chemistry Food Allergy
Current Pharmaceutical Design Male Pelvic Pain: Beyond Urology and Chronic Prostatitis
Current Rheumatology Reviews Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
Current Pharmaceutical Design Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
Current Pharmaceutical Design Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?
Current Neuropharmacology Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases
Current Pharmaceutical Design Clinical Management of Diabetes Mellitus in the Older Adult Patient
Current Diabetes Reviews Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry